Establishment Labs (NASDAQ:ESTA) Shares Up 6% – Time to Buy?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) shot up 6% during mid-day trading on Wednesday . The company traded as high as $46.50 and last traded at $45.88. 31,734 shares traded hands during trading, a decline of 92% from the average session volume of 385,023 shares. The stock had previously closed at $43.28.

Analysts Set New Price Targets

A number of brokerages have issued reports on ESTA. BTIG Research increased their price target on Establishment Labs from $62.00 to $65.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Stephens raised Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. Finally, Citigroup raised their price objective on Establishment Labs from $45.00 to $50.00 and gave the stock a “neutral” rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $60.60.

Establishment Labs Trading Up 8.3 %

The firm has a 50 day moving average price of $43.50 and a two-hundred day moving average price of $44.18. The firm has a market capitalization of $1.31 billion, a P/E ratio of -18.16 and a beta of 1.16. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Institutional Trading of Establishment Labs

A number of hedge funds have recently modified their holdings of the business. SkyView Investment Advisors LLC lifted its holdings in shares of Establishment Labs by 30.5% in the third quarter. SkyView Investment Advisors LLC now owns 12,000 shares of the company’s stock valued at $519,000 after purchasing an additional 2,805 shares in the last quarter. Barclays PLC lifted its holdings in shares of Establishment Labs by 9,643.3% in the third quarter. Barclays PLC now owns 31,471 shares of the company’s stock valued at $1,362,000 after purchasing an additional 31,148 shares in the last quarter. Redmile Group LLC lifted its holdings in shares of Establishment Labs by 22.9% in the third quarter. Redmile Group LLC now owns 261,803 shares of the company’s stock valued at $11,328,000 after purchasing an additional 48,779 shares in the last quarter. Point72 Asset Management L.P. raised its holdings in shares of Establishment Labs by 210.8% during the third quarter. Point72 Asset Management L.P. now owns 49,400 shares of the company’s stock worth $2,138,000 after acquiring an additional 33,507 shares in the last quarter. Finally, Portolan Capital Management LLC purchased a new stake in shares of Establishment Labs during the third quarter worth $2,446,000. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.